GR3008320T3 - - Google Patents

Info

Publication number
GR3008320T3
GR3008320T3 GR930400669T GR930400669T GR3008320T3 GR 3008320 T3 GR3008320 T3 GR 3008320T3 GR 930400669 T GR930400669 T GR 930400669T GR 930400669 T GR930400669 T GR 930400669T GR 3008320 T3 GR3008320 T3 GR 3008320T3
Authority
GR
Greece
Prior art keywords
cyclosporin
alone
valeronitriles
immunosuppressors
concurrently
Prior art date
Application number
GR930400669T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3008320T3 publication Critical patent/GR3008320T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR930400669T 1989-12-21 1993-06-30 GR3008320T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45600789A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
GR3008320T3 true GR3008320T3 (el) 1993-09-30

Family

ID=23811068

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400669T GR3008320T3 (el) 1989-12-21 1993-06-30

Country Status (10)

Country Link
EP (1) EP0434094B1 (el)
JP (1) JPH04210632A (el)
AT (1) ATE87614T1 (el)
CA (1) CA2033038A1 (el)
DE (1) DE69001240T2 (el)
DK (1) DK0434094T3 (el)
ES (1) ES2054207T3 (el)
GR (1) GR3008320T3 (el)
IE (1) IE64870B1 (el)
PT (1) PT96283A (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2498047T3 (es) 2007-06-20 2014-09-24 Milestone Pharmaceuticals Inc. Bloqueantes de los canales de calcio de fenilalquilamina de acción corta y usos de los mismos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
ATE87614T1 (de) 1993-04-15
EP0434094A1 (en) 1991-06-26
PT96283A (pt) 1991-09-30
IE904627A1 (en) 1991-07-17
CA2033038A1 (en) 1991-06-22
IE64870B1 (en) 1995-09-20
DK0434094T3 (da) 1993-08-16
JPH04210632A (ja) 1992-07-31
DE69001240T2 (de) 1993-08-05
EP0434094B1 (en) 1993-03-31
DE69001240D1 (de) 1993-05-06
ES2054207T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
EP0333606A3 (en) Preparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseases
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69430951D1 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
ATE281840T1 (de) Behandlung von diarrhoe
CY2231B1 (en) Compositions of oak bark extract related syntheticcompositions and method of using same
CS141387A2 (en) Microbicide
DE3685484D1 (el)
PH23818A (en) Enhancement of activity of alpha-adrenoceptor antagonists
GR3008320T3 (el)
AU7937691A (en) Parathyroid hypertensive factor
EP0344995A3 (en) Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ace inhibitor
GB2260702B (en) Improvements relating to the treatment of haemophilia B by subcutaneous injection of factor 1X
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
CA2288407A1 (en) Parathyroid hypertensive factor
RU96122672A (ru) Эхинамакс. способ лечения астенических состояний при физиогенных дезадаптациях
HUT43492A (en) Process for preventing and healing of gastrointestinic damages by using 3-ethoxicarbonil--1,6-dimethil-4-oxo-6,7,8,9-tetrahydro-4-h-pirido-/1,2-a/-pirimidinium-metha sulphate